People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Medication Review, Inc. | — | Pharmaceuticals | Pre-Seed | $195K | $9.2M | 2010 |
Chris R. Terriff, RPh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris R. Terriff, RPh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Adam R. Gelhausen | 1 | 1 |
| Dennis R. Hake | 1 | 1 |
| K. Douglas Crafton | 1 | 1 |
| Mary R. Giannini | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.